|
Thursday, March 9, 2017 8:57 PM
|
Venöse Multiple Sklerose, CVI & SVI, CCSVI shared CCSVI in Multiple Sclerosis's post.
Dr. Zamboni is tweeting this morning on the UBC trial, which he believes was created to fail, by including much older, progressive patients, already shown to have less of a response to venoplasty in his original study. The mean duration time w/MS was 20 years in the UBC #CCSVI trial. UBC drug trials only use younger, non progressive patients w/MS for under 10 years...why this double standard? #UBC #SIR17DC 
|